| View |
2020-12-18-0329
|
Hepatitis A (Inactivated) Vaccine (Adsorbed)
|
Havrix 720
|
BR-1303
|
AHAVC064AF
|
Packaging Lot Box & PFS: AHAVC064AF; Needle (25G x 5/8"): 200503 ED: 2025-04-30
|
31 March 2023
|
22 December 2020
|
| View |
2021-03-08-0111
|
Hepatitis A (Inactivated) Vaccine (Adsorbed)
|
HAVRIX 720
|
BR-1303
|
AHAVC064A
|
Packaging Lot (Box & PFS): AHAVC064AO; Needle: 2004058
|
31 March 2023
|
09 March 2021
|
| View |
2021-05-06-0206
|
RITUXIMAB
|
MABTHERA
|
BR-1141
|
H0320B41
|
Packaging Lot (Box): H0320B41; (Vial): H0320
|
31 March 2023
|
10 May 2021
|
| View |
2021-05-27-0243
|
INSULIN GLARGINE
|
GLYSOLIN G
|
BRP-037-01
|
DV10420
|
Packaging lot (Box & Cartridge with Pen): DV10420
|
31 March 2023
|
31 May 2021
|
| View |
2021-05-27-0244
|
INSULIN GLARGINE
|
GLYSOLIN G
|
BRP-037-01
|
DV10421
|
Packaging lot (Box & Vial): DV10421
|
31 March 2023
|
28 May 2021
|
| View |
2021-07-05-0312
|
DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
|
INFANRIX HEXA
|
BR-508
|
A21CD919 (DTPa-HBV-IPV: AC21DB775B; HiB: AHIBD469C)
|
Packaging Lot (Box): A21CD919B; (Pre-filled Syringe-PFS): A21LD919B; (Vial): A21FD919B; (Needle 25G x 1"): 2008035
|
31 March 2023
|
8 July 2021
|
| View |
2021-07-05-0315
|
FOLLITROPIN ALFA/ LUFTROPIN ALFA
|
PERGOVERIS
|
BR-1318
|
BA072781
|
Packaging Lot (Box & Pre-filled pen): BA072781
|
31 March 2023
|
8 July 2021
|
| View |
2021-07-23-0350
|
FOLLITROPIN ALFA / LUTROPIN ALFA
|
PERGOVERIS
|
BR-1318
|
BA073085
|
Packaging Lot (Box & Pre-filled Pen): BA073085
|
31 March 2023
|
26 July 2021
|
| View |
2021-07-23-0351
|
FOLLITROPIN ALFA / LUTROPIN ALFA
|
PERGOVERIS
|
BR-1318
|
BA072857
|
Packaging Lot (Box & Pre-filled Pen): BA072857
|
31 March 2023
|
26 July 2021
|
| View |
2021-08-20-0446
|
INACTIVATED POLIOMYELITIS VACCINE (TYPES 1, 2 AND 3)
|
IMOVAX POLIO
|
BR-498
|
U3E58
|
Packaging Lot (Box): U3E583V; (Pre-filled Syringe): U3E58
|
31 March 2023
|
25 August 2021
|
| View |
2021-12-06-0544
|
RECOMBINANT B-SUBUNIT/INACTIVATED WHOLE CELL CHOLERA VACCINE
|
ORAVACS
|
BR-664
|
202104P12
|
Packaging Lot (Box & Vial): 202104P12
|
31 March 2023
|
10 December 2021
|
| View |
2021-06-18-0281
|
CETUXIMAB
|
ERBITUX
|
BR-1050
|
G0127L
|
Packaging Lot (Box & Vial): G0127L
|
31 March 2024
|
22 June 2021
|
| View |
2021-07-07-0330
|
INSULIN GLARGINE
|
GLYSOLIN G
|
BRP-037-01
|
DW10258
|
Packaging Lot (Box & Cartridge): DW10258
|
31 March 2024
|
12 July 2021
|
| View |
2021-10-26-0507
|
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)
|
SYNFLORIX
|
BR-1310
|
ASP4A285A
|
Packaging Lot (Box & Vial): ASP4A285AA
|
31 March 2024
|
28 October 2021
|
| View |
2021-10-26-0508
|
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)
|
SYNFLORIX
|
BR-1310
|
ASP4A287A
|
Packaging Lot (Box & Vial): ASP4A287AA
|
31 March 2024
|
28 October 2021
|
| View |
2021-10-27-0510
|
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)
|
SYNFLORIX
|
BR-1310
|
ASP4A286A
|
Packaging Lot (Box & Vial): ASPA4A286AA
|
31 March 2024
|
29 October 2021
|
| View |
2021-12-22-0559
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0161N018
|
Packaging Lot (Box & Vial): 0161N018; (Diluent): 0681S1086; 0681S1087; 0681S1088
|
31 March 2024
|
24 December 2021
|
| View |
2021-12-22-0560
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0161N019
|
Packaging Lot (Box & Vial): 0161N019; (Diluent): 0681S1086; 0681S1087; 0681S1088
|
31 March 2024
|
24 December 2021
|
| View |
2021-12-22-0561
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0161N020
|
Packaging Lot (Box & Vial): 0161N020; (Diluent): 0681S1086; 0681S1087; 0681S1088
|
31 March 2024
|
24 December 2021
|
| View |
2022-01-14-0007
|
MEASLES VACCINE ( LIVE, ATTENUATED )
|
M-VAC
|
BR-349
|
0011N005
|
Packaging Lot (Box & Vial): 0011N005; (Diluent): 0640S4001
|
31 March 2024
|
19 January 2022
|